Dr. Boris Lorberg is an academic child and adolescent psychiatrist, board-certified in both general and child psychiatry. Born and raised in Kyiv, Ukraine, he earned his medical degree from Stony Brook University School of Medicine (USA) in 2004. He completed his General Psychiatry Residency at Yale University (Levine Award for Clinical Excellence, Breadth of Learning, and Dedication to the Care of Severely Ill Psychiatric Patients). He then pursued a Child and Adolescent Psychiatry Fellowship at Harvard University (MGH/McLean Hospital), receiving the Laughlin Award from the American College of Psychiatrists, a prestigious recognition for future leaders in the field. In 2017, he expanded his expertise in healthcare leadership by earning a Physician’s MBA from the Heller School of Social Policy and Management at Brandeis University.

Dr. Lorberg has made significant contributions to psychiatric education, psychopharmacology, and professional development. He has played an integral role in the American Academy of Child and Adolescent Psychiatry (AACAP), leading national forums and workshops on pediatric psychopharmacology, early career mentorship, and leadership training. From 2009 to 2014, he led a workgroup within AACAP’s Pediatric Psychopharmacology Initiative (PPI), where he helped develop clinical resources on FDA indications and evidence quality for psychotropic medications in children. He also co-authored the AACAP-APA Parent Medication Guides for childhood depression, ADHD, and bipolar disorder, which remain freely available to families and clinicians (http://www.parentsmedguide.org/).

Dr. Lorberg has been deeply engaged in academic psychiatry. He served as Co-Chair of AACAP’s Early Career Psychiatrist Committee (2011–2014) and has been a Section Editor for the Psychopharmacology Corner of AACAP News since 2019. Dr. Lorberg has also led IACAPAP Textbook’s updates on its Chapter about general psychopharmacology principles. In 2023, he was appointed Co-Chair of AACAP’s Psychopharmacology and Neurotherapeutics Committee. His academic leadership extends to editorial and research roles, including serving on a Data and Safety Monitoring Board (DSMB) for a national multi-site study on psychiatric treatment outcomes in suicidal adolescents. In 2024, he assembled a team of international experts, edited, and published Pediatric Psychopharmacology Evidence: A Clinician’s Guide (Springer Nature), a key textbook for everyone who prescribes psychiatric medications to children.

Clinically, Dr. Lorberg has extensive experience in treating youth with severe and treatment-refractory mental illness. He joined the University of Massachusetts Medical School (UMass Chan) in 2009, where he served as Medical Director of the Adolescent Intensive Residential Treatment Program and later as Medical Director of the Adolescent Continuing Care Inpatient Units at Worcester Recovery Center and Hospital (WRCH). In 2024, he transitioned to community psychiatry as the Medical Director of the Community Behavioral Health Center in Lawrence, MA, part of Beth Israel Lahey Health Behavioral Services.

His work in physician education and wellness includes co-leading mindfulness-based leadership initiatives through a Mindful Physician Leadership Grant from the Physician’s Foundation (2016–2018). He has also developed and facilitated a year-long leadership coaching program curriculum for UMass psychiatry faculty, staff, and residents since 2015.

Since 2018, through IACAPAP’s networking, Dr. Lorberg has started to build collaborations with Ukrainian child psychiatrists. He recruited numerous speakers to the annual Ukrainian child psychiatry educational conferences and provided support for epidemiological research efforts in Ukrainian child mental health. Dr. Lorberg has worked on development of a unique international center for mental and physical rehabilitation for war-affected children in Ukraine, Nadija Children’s Hospital and Research Institute.

Through his commitment to clinical care, education, and mentorship, Dr. Lorberg continues to advance the field of child and adolescent psychiatry, shaping the next generation of psychiatric leaders.